| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35280-10ug | |||
| Carrier-Free | NBP2-35280-1mg | |||
| Carrier-Free | NBP2-35280-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34884-10ug | |||
| Carrier-Free | NBP2-34884-1mg | |||
| Carrier-Free | NBP2-34884-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35257-10ug | |||
| Carrier-Free | NBP2-35257-1mg | |||
| Carrier-Free | NBP2-35257-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35061-10ug | |||
| Carrier-Free | NBP2-35061-1mg | |||
| Carrier-Free | NBP2-35061-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35102-10ug | |||
| Carrier-Free | NBP2-35102-1mg | |||
| Carrier-Free | NBP2-35102-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35112-1mg | |||
| Carrier-Free | NBP2-35112-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35254-10ug | |||
| Carrier-Free | NBP2-35254-1mg | |||
| Carrier-Free | NBP2-35254-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35153-1mg | |||
| Carrier-Free | NBP2-35153-100ug | |||
| Carrier-Free | NBP2-35153-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12021-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34909-10ug | |||
| Carrier-Free | NBP2-34909-1mg | |||
| Carrier-Free | NBP2-34909-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34911-1mg | |||
| Carrier-Free | NBP2-34911-100ug | |||
| Carrier-Free | NBP2-34911-500ug | |||
![SDS-Page: Recombinant Rat Oncostatin M/OSM Protein [NBP2-35280]](http://images.novusbio.com/fullsize/Recombinant-Rat-Oncostatin-M-OSM-Protein-SDS-Page-NBP2-35280-img0002.jpg "SDS-Page: Recombinant Rat Oncostatin M/OSM Protein [NBP2-35280]")
![SDS-Page: Human G-CSF Protein [NBP2-34884]](http://images.novusbio.com/fullsize/Human-G-CSF-Protein-SDS-Page-NBP2-34884-img0001.jpg "SDS-Page: Human G-CSF Protein [NBP2-34884]")
![SDS-Page: Rat IL-9 Protein [NBP2-35257]](http://images.novusbio.com/fullsize/Rat-IL-9-Protein-SDS-Page-NBP2-35257-img0001.jpg "SDS-Page: Rat IL-9 Protein [NBP2-35257]")
![SDS-Page: Mouse G-CSF Protein [NBP2-35061]](http://images.novusbio.com/fullsize/Mouse-G-CSF-Protein-SDS-Page-NBP2-35061-img0001.jpg "SDS-Page: Mouse G-CSF Protein [NBP2-35061]")
![SDS-Page: Mouse IL-11 Protein [NBP2-35102]](http://images.novusbio.com/fullsize/Mouse-IL-11-Protein-SDS-Page-NBP2-35102-img0001.jpg "SDS-Page: Mouse IL-11 Protein [NBP2-35102]")
![SDS-Page: Mouse Oncostatin M/OSM Protein [NBP2-35112]](http://images.novusbio.com/fullsize/Mouse-Oncostatin-M-OSM-Protein-SDS-Page-NBP2-35112-img0001.jpg "SDS-Page: Mouse Oncostatin M/OSM Protein [NBP2-35112]")
![SDS-Page: Rat IL-6 Protein [NBP2-35254]](http://images.novusbio.com/fullsize/Rat-IL-6-Protein-SDS-Page-NBP2-35254-img0001.jpg "SDS-Page: Rat IL-6 Protein [NBP2-35254]")
![SDS-Page: Mouse LIF Protein [NBP2-35153]](http://images.novusbio.com/fullsize/Mouse-LIF-Protein-SDS-Page-NBP2-35153-img0001.jpg "SDS-Page: Mouse LIF Protein [NBP2-35153]")
![Immunocytochemistry /Immunofluorescence: Fibrin beta-chain Antibody (59D8) - Chimeric - BSA Free [NBP3-43555] - Immunofluorescence analysis of paraformaldehyde fixed HepG2 cells on Shi-fix coverslips stained with NBP3-43555 (1:100 dilution) for 1h followed by Alexa Fluor 488 secondary antibody (1:1000 dilution), showing cytoplasmic staining. The nuclear stain is DAPI (blue). Panels show, from left-right, top-bottom, NBP3-43555, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/nbp3-43555_rabbit-fibrin-beta-chain-mab-59d8-chimeric-azide-bsa-free-7420252214120.png "Immunocytochemistry /Immunofluorescence: Fibrin beta-chain Antibody (59D8) - Chimeric - BSA Free [NBP3-43555] - Immunofluorescence analysis of paraformaldehyde fixed HepG2 cells on Shi-fix coverslips stained with NBP3-43555 (1:100 dilution) for 1h followed by Alexa Fluor 488 secondary antibody (1:1000 dilution), showing cytoplasmic staining. The nuclear stain is DAPI (blue). Panels show, from left-right, top-bottom, NBP3-43555, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor 488 secondary antibody.")
![Western Blot: Fibrin beta-chain Antibody (59D8) - Chimeric - BSA Free [NBP3-43555] - Human liver (A), placenta (B), and serum (C) tissue lysates (35ug protein in RIPA buffer) were resolved via SDS-PAGE, and the subsequent blots were probed with NBP3-43555 at 0.01ug/ml before detection using an anti-rabbit secondary antibody. A primary incubation of 1 hour was used, and proteins were detected by chemiluminescence.](http://images.novusbio.com/fullsize/nbp3-43555_rabbit-fibrin-beta-chain-mab-59d8-chimeric-azide-bsa-free-74202522113014.png)
![Flow Cytometry: IL-9 Antibody (D9302C12) - Chimeric [NBP3-12021] - Mouse splenocytes were stimulated with PMA and Ionomycin in presence of Monensin for 4 hours. The cells were fixed using 2% PFA, permeabilized using 0.5% Triton and stained with anti-Fluorescein IgG antibody (4-4-20; isotype control, black line) or the rabbit IgG version of D9302C12 (NBP3-12021, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-mouse IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells were analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/IL-9-Antibody-D9302C12-Chimeric-Flow-Cytometry-NBP3-12021-img0001.jpg "Flow Cytometry: IL-9 Antibody (D9302C12) - Chimeric [NBP3-12021] - Mouse splenocytes were stimulated with PMA and Ionomycin in presence of Monensin for 4 hours. The cells were fixed using 2% PFA, permeabilized using 0.5% Triton and stained with anti-Fluorescein IgG antibody (4-4-20; isotype control, black line) or the rabbit IgG version of D9302C12 (NBP3-12021, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-mouse IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells were analyzed using a FACSCanto flow-cytometer.")
![SDS-Page: Human IL-9 Protein [NBP2-34909]](http://images.novusbio.com/fullsize/Human-IL-9-Protein-SDS-Page-NBP2-34909-img0001.jpg "SDS-Page: Human IL-9 Protein [NBP2-34909]")
![SDS-Page: Human CXCL10/IP-10/CRG-2 Protein [NBP2-34911]](http://images.novusbio.com/fullsize/Human-CXCL10-IP-10-CRG-2-Protein-SDS-Page-NBP2-34911-img0001.jpg "SDS-Page: Human CXCL10/IP-10/CRG-2 Protein [NBP2-34911]")